An estimated 300,000 children in the U.S. — that’s 1 in 250 kids — are affected by some form of JA. This disease takes a unique physical and emotional toll on kids, often resulting in debilitating pain and feelings of loneliness or depression. JA can make it especially challenging for kids to say Yes — Yes to playing, Yes to hanging out with friends, Yes to spending time with family, Yes to being a kid!
Please join the Arthritis Foundation for the 2019 JA Symposium. Dr. Jordan Jones of Children’s Mercy Hospital will speak to families about the latest advancements in pediatric rheumatology. Arthritis Foundation staff will share what we do to try and help you and your family in navigating life with juvenile arthritis. At the end of our program each family will be provided free tickets to the exhibit at Union Station as well as tickets to visit Science City!
There is no cost to attend this event. You must pre-register all members of your family that will be in attendance. Enter the number of people attending the event below and click next. On the second page you will be asked to enter information for all those attending. Once submitted you will receive an email confirming your reservation.
Registration refund requests must be submitted in writing to the RAI Executive Office no later than 2/7/2019. All refund requests will be subject to a $5.00 processing fee. No refunds will be made after 2/7/2019.
For accommodations on the basis of disability or special dietary needs, please call (847) 517-7225.
Program Schedule Information
Effective management in ANCA-associated vasculitis (AAV), specifically Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) include not only the use of evidence-based treatments but also rigorous application of monitoring and preventive strategies to reduce the risk of infection and medication-specific toxicities. Rheumatologists need to be aware of these strategies to provide their patients with the best outcomes.
For the two main forms of Large-vessel vasculitis (LVV), Giant Cell Arteritis (GCA) and Takayasu Arteritis (TAK), non-medical management should be considered for disease that is threatening a critical organ or for significant symptoms impacting quality of life.
Today’s challenging health care environment is affecting the way physicians manage their practices, interfering with access to care and forcing them to make difficult decisions. Physicians seek to continue to provide quality care while contending with reduced Medicare reimbursement rates, medical claims, process errors and inefficiency, and legislative and regulatory changes. Rheumatologists need to be aware of emerging trends in practice management, payer reform, and administrative simplification of impact to the success of their practices and quality of patient care.
At the conclusion of the RAI 2019 5th Annual Meeting, attendees will be able to:
Recognize federal efforts to improve value in healthcare delivery and payment through programs established under the Medicare Access and CHIP Reauthorization Act (MACRA)
Distinguish and contrast pathways for Rheumatologists to be reimbursed under the Quality Payment Program (i.e., the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs).
Evaluate the potential impact of MACRA on Rheumatology practices and estimate the significance of engagement in current and future value-driven delivery and payment models.
Identify opportunities for state and national advocacy, legislative action and our need for representation at the state national level.
Identify the clinical features of ANCA-associated vasculitis.
Describe the approach to diagnosis for ANCA-associated vasculitis.
List the treatment options for ANCA-associated vasculitis.
Describe the diseases that can be associated with large vessel vasculitis.
Identify the clinical features associated with giant cell arteritis and Takayasu arteritis.
Discuss the treatment approaches to giant cell arteritis and Takayasu arteritis.
The Rheumatology Association of Iowa (RAI) 5th Annual Meeting will be held during March 1 – 2, 2019 at The Hotel at Kirkwood Center, Cedar Rapids, Iowa, United States of America. All sessions will be located in Amphitheater unless otherwise noted. Speakers & times are subject to change
FRIDAY, MARCH 01, 2019
3:00 p.m. – 7:00 p.m. Registration/Information Desk Location: Student Common Area
5:30 p.m. – 7:00 p.m. Exhibit Hall Open Location: Student Common Area
6:00 p.m. – 7:00 p.m. Welcome Reception in Exhibit Hall
5:00 p.m. – 5:05 p.m. Welcome & Opening Remarks
RAI President: Michael S. Brooks, MD, FACP, FACR
5:05 p.m. – 6:00 p.m. How Current Iowa Laws Passed Affect those Practicing Rheumatology Today
Speaker: Doug Ommen
Iowa Insurance Division
5:30 p.m. – 7:00 p.m. Exhibit Hall Open
Location: Student Common Area
SATURDAY, MARCH 02, 2019
7:30 a.m. – 4:00 p.m. Registration/Information Desk Location: Student Common Area
8:00 a.m. – 2:00 p.m. Exhibit Hall Open Location: Student Common Area
8:00 a.m. – 9:00 a.m. Practice Management Networking Breakfast Location: H Classroom 185
8:00 a.m. – 9:00 a.m. Continental Breakfast in Exhibit Hall Location: Exhibit Hall
9:00 a.m. – 9:15 a.m. Welcome & Announcements
9:15 a.m. – 10:15 a.m. Keynote Lecture I Vasculitis
Speaker: Carol A. Langford, MD, MHS, FACP
Cleveland Clinic Foundation
10:15 a.m. – 10:45 a.m. Break/Visit Exhibits
10:45 a.m. – 11:45 a.m. Keynote Lecture II Vasculitis
Speaker: Carol A. Langford, MD, MHS, FACP
Cleveland Clinic Foundation
11:45 a.m. – 12:30 p.m. RAI Annual Business Meeting Location: Amphitheater
1:30 p.m. – 2:00 p.m. Dessert & Networking in Exhibit Hall
2:00 p.m. – – 4:00 p.m. Advocacy Panel/Presentations
CSRO State Issues
ACR Federal Issues
Iowa Medical Society
Continuing Education Credit
DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 5.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Rheumatology Association of Iowa. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 5.0 continuing education contact hour(s). No partial credit awarded.
Other: This live activity is designated for 5.0 AMA PRA Category 1 Credit(s)™.
The statements and opinions contained in this program are solely those of the individual authors and contributors and not of the Rheumatology Association of Iowa or Des Moines University (DMU). The appearance of the advertisements is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. The content of this publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. RAI disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the abstracts or advertisements.
We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Call (847) 517-7225 if you require special assistance to fully participate in the meeting.
No commercial interest company provided financial support for this continuing education activity.